Podcasts about Boston Scientific

In this episode of Medsider Radio, we sat down with Marc Penna, CEO of Voyager Biomedical. Voyager is a clinical-stage company tackling one of the most persistent challenges in dialysis care: reliable vascular access. Marc has more than 20 years of experience leading clinical research and regulatory programs across cardiology, vascular disease, and oncology. Since 2014, he has focused on early-stage ventures, with leadership roles at Intact Vascular and Vesper Medical — both acquired by Philips — as well as senior positions at Edwards Lifesciences, Boston Scientific, and AngioDynamics.In this interview, Marc shares how to pressure-test new medtech ideas, why collaboration with regulators and trial sites builds lasting credibility, and how disciplined fundraising and smart exit planning can set startups apart.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Marc Penna.

This episode of the Next Level Healing Podcast is the recording of a webinar hosted by Dr. Tara Perry and John K. Bates, a visionary TED and TEDx coach who trained and coached leaders at NASA—including the astronauts—GE Aerospace, US Navy Special Operations, Johnson & Johnson's JLABS, Boston Scientific, Google, and Intuit.  Dr. Tara and John answer participant questions about storytelling, branding, business, transformation, and so much more.This is a conversation you don't want to miss!Work with Dr. Tara PerryTune in every week for a new episode of Next Level Healing. Subscribe on your favorite podcasting platform and never miss an episode!

I've been eager to share with all of you in podcast land some important information and history about what I believe is one of the key drivers in helping fulfill the Michael J. Fox Foundation's mission to cure Parkinson's disease. The Parkinson's Progression Markers Initiative (PPMI), launched in 2010, is a groundbreaking study involving people both with and without Parkinson's. It gathers data over time to help researchers better understand how Parkinson's starts, how it progresses, and — most importantly — how to stop it. Sound important? It absolutely is. And it's still going strong, continually recruiting new participants to join its large and growing community of volunteers. The more data we collect through PPMI, the faster we can accelerate the path to a cure. Maggie Kuhl and Alyssa O'Grady are at the heart of this effort — overseeing the data, bringing in new participants, and tracking the initiative's progress every step of the way. Listen to what the experts say about how you can contribute to the solution to the Parkinson's puzzle. Thank you to our sponsor – Boston Scientific, the maker of Vercise Genus, a Deep Brain Stimulation or DBS system. To learn more about the latest treatment options for Parkinson's disease at https://DBSandMe.com/17branches   https://www.michaeljfox.org/ppmi https://www.ppmi-info.org/    

The FDA Group's Nick Capman speaks with Marcus Gesner, Vice President of Global Quality at embecta. With more than two decades of leadership experience at companies including Boston Scientific, Olympus, Covidien, JUUL Labs, and others, Marcus brings a unique perspective to what makes a quality organization truly high-performing.Marcus shares why compliance is only the baseline “entry fee” for quality—and how high-functioning teams go further by protecting a company's right to compete, preventing manufacturing and supply disruptions, enabling speed to market, and building trust across the business.He discusses the metrics that matter most (like defect rates, back orders, holds, complaints, and R&D delays), how to structure incentives that drive the right behaviors, and practical strategies for recruiting, onboarding, and retaining people with the drive, courage, and creativity to lead meaningful change.Nick and Marcus also explore how leaders can create the right balance of accountability and innovation, foster collaboration across functions, and ensure quality is seen as a value-driving partner rather than a cost center or policing function.About The FDA Group:The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

Falar de emagrecimento está em alta, e os tratamentos modernos para a obesidade são cada vez mais eficazes e seguros. Neste episódio do DrauzioCast, o dr. Drauzio conduz uma conversa com dois especialistas: o dr. Bruno Halpern, endocrinologista e presidente da World Obesity Federation, sobre os avanços dos medicamentos; e o dr. Gustavo Quadros, cirurgião e endoscopista, que explica os resultados dos procedimentos endoscópicos e cirúrgicos.Conteúdo produzido com o apoio da Boston Scientific e seu canal Saber da Saúde.Veja também: Como o Ozempic age no corpo

In this episode of Medsider Radio, we sat down with Howard Rosen, co-Founder and CEO of Evident Vascular, a company developing an AI-powered intravascular ultrasound (IVUS) platform to improve vascular imaging and intervention. Before co-founding Evident, Howard held senior leadership roles at Intact Vascular and Vesper Medical, guiding both companies through successful acquisitions by Philips. He also served in executive roles at Haemonetics and BG Medicine, and spent over two decades at Boston Scientific, where he held a range of leadership positions across the peripheral and cardiovascular franchises.In this interview, Howard shares why launching right — not fast — is the key to success in medtech. He breaks down how Evident built early momentum by investing in deep market validation, engaging KOLs as true collaborators, and resisting scope creep at every turn. Howard also unpacks the company's deliberate regulatory strategy, using early FDA engagement as a tool to de-risk development. On the fundraising front, he explains why board composition matters more than valuation, and why strategic acquirers respond best to credibility, not cold outreach.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Howard Rosen.

From consulting to working at large companies to taking a risk with start-ups to becoming Silk Road Medical's CEO, Chas McKhann has experienced almost everything in his long and illustrious career. In a discussion with Medtech Talk host Geoff Pardo, McKhann shares all the lessons learned from his jump to small private companies, handling a cultural rebirth as a newcomer CEO under the public eye, and taking on his role at Silk Road. He also talks about the “what if's” of his journey and tips on surviving in the industry, as well as witnessing the market shift from only caring about revenue to wanting to see the path to capital break even. LINKS: Medtech Talk Links:  Cambridge Healthtech Institute   Medtech Talk  Gilde Healthcare  Silk Road Medical: Silk Road Medical  

Listening to personal Parkinson's stories offers valuable insights for everyone. In this episode, we interview Greg Ritscher, who responded to his diagnosis with determination shaped by his business and personal experiences. Greg also shares a notable DBS story. His journey highlights motivation, positivity, community support, and advocacy. Enjoy our inspiring conversation with Greg.  https://gregritscher.com/ https://www.dbsandme.com/17branches Thank you to our sponsor – Boston Scientific, the maker of Vercise Genus, a Deep Brain Stimulation or DBS system. To learn more about the latest treatment options for Parkinson's disease at https://DBSandMe.com/17branches   

William H. Sauer, MD, FHRS, Brigham and Women's Hospital is joined by Wendy S. Tzou, MD, FHRS, University of Colorado Anschutz Medical Campus and Kishan Padalia, MD, University of Colorado, to discuss the results of ablation of sustained monomorphic ventricular tachycardia (SMVT) are suboptimal. For many patients with implantable cardioverter-defibrillators (ICDs), ICD electrograms (ICD-EGs) provide the only available information on SMVT. ICD-EGs have the ability to distinguish morphologically distinct SMVT and can be used for pace mapping.  https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacc.2024.10.104 Host Disclosure(s): W. Sauer:  Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic  Contributor Disclosure(s): W. Tzou: Honoraria/Speaking/Consulting: Medtronic, Biotronik, Biosense Webster, Inc., Mediasphere Medical, Kardium, American Heart Association, Medtronic, Abbott, BioTelemetry, Boston Scientific, Kardium Research: Abbott Medical K. Padalia: Nothing to disclose.

 Ken Shreve and Ed Carson analyze Wednesday's market action and discuss key stocks to watch on Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

In der heutigen Folge sprechen die Finanzjournalisten Lea Oetjen und Holger Zschäpitz über Börsen-Non-Event Alaska, eine hoffnungsvolle Softwarestudie mit 6 Top Picks und einen neuen Chart of Doom. Außerdem geht es um CoreWeave, Salesforce, Siemens Energy, Cisco Systems, Palo Alto Networks, ProSiebenSat.1, Novo Nordisk, AstraZeneca, AbbVie, Siemens Healthineers, Sonova, Medtronic, Haleon, iShares Aging Population ETF (WKN: A2ANH1), Boston Scientific, Glaukos, Exelixis, Sarepta, Swisscanto Healthy Longevity Fund (WKN: A40L0T), Eli Lilly, Abbott, UnitedHealth, Microsoft, Amazon, Nvidia, Meta, Netflix, Coreweave, Oracle, Carvana, TSMC, Roblox, Crowdstrike, Opendoor Technologies, Alibaba, PDD, Petroleo Brasileiro, Teva Pharmaceutical, Robinhood, Northrop Grumman, RTX, Lululemon, Mercadolibre, Talen Energy, GE Vernova, Broadcom, Vistra, Micron, Alphabet, Somnigroup International, Flutter Entertainment. Und hier gibt es die Tickets zum Finance Summit am 17. September! https://veranstaltung.businessinsider.de/FinanceSummit Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Deep Chandh Raja, MBBS, MD, PhD, Australian National University, Kauvery Hospital is joined by Andreas Pflaumer, MD, FHRS, CEPS-P, Royal Children's Hospital Melbourne and Maully J. Shah, MBBS, FHRS, CCDS, CEPS-P Children's Hospital of Philadelphia, to discuss the unmet clinical need for a smaller pacemaker suitable for neonates and infants, researchers developed a specially modified implantable pulse generator incorporating a Medtronic Micra subassembly within a polymer header, connected to a bipolar epicardial lead. This study aimed to evaluate the safety, feasibility, and midterm outcomes of this novel device, reporting follow-up data from multiple centers on patients who underwent implantation. https://www.hrsonline.org/education/TheLead https://www.ahajournals.org/doi/10.1161/CIRCEP.124.013436?doi=10.1161/CIRCEP.124.013436 Host Disclosure(s): D. Raja:  Nothing to disclose. Contributor Disclosure(s): M. Shah: Honoraria/Speaking/Consulting: Medtronic, IBHRE Abbott, BioTelemetry, Boston Scientific, Kardium Other Financial Relationships: American College of Cardiology A. Pflaumer: Stock Options - Privately Held: Navi Medical Systems Officer, Trustee, Director, Committee Chair: PACES, Asia Pacific Heart Rhythm Society (APHRS)

B2B buyers now expect the same speed, personalization, and precision they enjoy in consumer shopping—and that expectation is redefining digital commerce. In this episode, inspired by How Boston Scientific uses AI search to transform B2B commerce + boost conversions, we break down how AI-powered search is closing the experience gap, boosting conversions, and creating measurable ROI.With insights from Boston Scientific's digital transformation journey, we explore how they tackled search performance challenges, integrated Coveo's AI relevance platform into SAP Commerce Cloud, and deployed an “intent box” to unify search and chat into a single entry point. The results: faster customer experiences, empowered sales teams, higher retention, and a staggering 300% growth in online order revenue.What You'll Learn in This Episode:The Experience Gap in B2B CommerceWhy B2B buyers expect Amazon-level experiencesHarvard Business Review study: 70% say AI is essential for e-commerce's futureCommon barriers: data privacy, skills gaps, executive alignmentWhat Makes AI-Powered Search DifferentEnriched intent detection that understands buyer needsAutomatic re-ranking and behavior-based recommendationsQuestion answering and dynamic content filtering to reduce frictionBoston Scientific's Search TransformationIntegrating Coveo's AI platform with SAP Commerce CloudCentralizing content from 55+ sources into one intelligent indexPersonalizing search results for both customers and sales repsThe “Intent Box” InnovationUnifying search and chat into one smart entry pointDelivering fast, accurate, contextual answers from anywhere in the siteChanging the way customers interact with digital channelsMeasurable Impact and ROI20%+ jump in search conversion ratesCustomers discovering and purchasing new products via searchReduced customer service calls and improved self-service300% increase in online order revenueKey Lessons for AI Success in B2BStart with the business problem, not the platformFocus on relevance, not just channelsPartner with providers who offer both technology and strategic guidanceKey Takeaways:AI search can close the B2B experience gap and boost customer satisfactionUnified, intent-driven experiences speed up buying and sellingStrategic alignment between tech and business goals drives ROIIntegration with existing platforms preserves flexibility while adding intelligenceRelevance is the ultimate metric for digital commerce successSubscribe to our podcast for expert insights on AI in commerce, B2B digital transformation, and customer experience innovation. Visit The Future of Commerce for in-depth research on how technology is driving measurable business results. Share this episode with digital leaders, e-commerce managers, and sales enablement teams looking to close the experience gap.

Melissa E. Middeldorp, MPH, PhD is joined by Martin K. Stiles, MBChB, PhD, FHRS, University of Auckland and Waikato Hospital and Eloi Marijon, MD, PhD, Paris University & European Georges Pompidou Hospital, to discuss this Danish nationwide study examines the relationship between socioeconomic position (SEP) and sudden cardiac death (SCD) as well as all-cause mortality (ACM). Analyzing all deaths in Denmark from 2010, researchers found a strong inverse association between both income and education level and the risk of SCD and ACM. Individuals in the lowest income and education groups had significantly higher rates of SCD, even after adjusting for age, sex, and comorbidities. The study highlights that despite Denmark's universal healthcare system, socioeconomic disparities in health outcomes persist, suggesting that factors beyond healthcare access—such as health literacy, lifestyle, and systemic inequalities—play a crucial role. The findings call for further research into the mechanisms driving these disparities and the development of targeted prevention strategies.  https://www.hrsonline.org/education/TheLead https://academic.oup.com/europace/article/27/4/euaf001/7958953?login=false Host Disclosure(s): M. Middeldorp: Nothing to disclose. Contributor Disclosure(s): E. Marijon: Honoraria/Speaking/Consulting: Zoll Medical Corporation, Boston Scientific  Research: Biotronik, Boston Scientific, MicroPort Scientific Corporation, Medtronic, Zoll Medical Corporation, Abbott  M. Stiles: Honoraria/Speaking/Consulting: Abbott Medical, Medtronic, Inc., Boston Scientific

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and deaths. AP's Lisa Dwyer reports.

The range of symptoms and affected body systems in Parkinson's disease is extensive. One area that is less frequently discussed is the vestibular system—the inner ear structure directly connected to the brain, responsible for balance and spatial orientation. When this system malfunctions, individuals may experience dizziness, balance problems and an increased risk of falls, highlighting its importance in your overall health. With aging, the inner ear naturally becomes less robust. Although current research has not yet identified a definitive cause for the higher incidence of vestibular dysfunction in people with Parkinson's disease, effective interventions are available. In this episode, Christopher Taylor, Occupational Therapist at Mayo Clinic, will provide insights into the diagnosis and treatment options—namely vestibular therapy—that can assist with symptoms such as dizziness, gait disturbances, freezing, and postural instability. This discussion aims to enhance our understanding of the crucial role played by the inner ear and its connections. Thank you to our sponsor – Boston Scientific, the maker of Vercise Genus, a Deep Brain Stimulation or DBS system. To learn more about the latest treatment options for Parkinson's disease at https://DBSandMe.com/17branches  https://vestibular.org/

Melissa E. Middeldorp, MPH, PhD is joined by Thomas F. Deering, BS, MBA, MD, FHRS, CCDS, and T. Jared Bunch, MD, FHRS to discuss a 31-item questionnaire was developed and distributed among healthcare professionals via the EHRA network and social media between 23 September and 21 October 2024. https://www.hrsonline.org/education/TheLead https://academic.oup.com/europace/article/27/4/euaf075/8099191?login=false Host Disclosure(s): M. Middeldorp: Nothing to disclose. Contributor Disclosure(s):   T. Deering: Honoraria/Speaking/Consulting: Sanofi, Pacemate, Pfizer, Inc., Omny Health, Preventice Research: Abbott, Boston Scientific, Medtronic, Biotronik, Biosense Webster, Inc.,  Stock Options - Privately Held: HeartBeam Officer, Trustee, Director, Committee Chair: Board Membership T. Bunch: Honoraria/Speaking/Consulting: Pfizer, Inc. Heart Rhythm Society

What does it really take to lead with empathy in today's fast-paced world? Today we invited Angie Morgan, a New York Times bestselling author and Marine Corps veteran. She reveals how blending mission-driven leadership with genuine care for your people creates unstoppable teams.   In this insightful conversation, Angie dives deep into the evolving world of leadership. From her time in the Marine Corps to leading multinational companies, Angie teaches us how empathy, clarity, and courage are the foundation for effective leadership. Learn how to strike the balance between caring for your team and driving results without compromising your mission. Whether you're a leader or aspiring to be one, this episode is packed with real-world wisdom that will help you rise to your best leadership potential.   Here are highlights:   -Empathy in Leadership: How understanding and connecting with your team's emotions fosters stronger performance and results, without lowering expectations. -Leading from the Front: The Marine Corps philosophy of "Mission First, People Always" and how it can transform your approach to leadership in any business. -The Power of Clarity: Angie explains how getting clear on your vision and purpose is the first step toward leading yourself and others effectively. -Courage to Take Risks: Why embracing calculated risks is essential for leadership growth, and how to overcome the fear of failure. -Authenticity in Leadership: Angie reflects on the importance of leading as your true self and how authenticity breeds trust and respect within your team.   About the guest: Angie Morgan is a respected author, leadership expert, and thought leader, having written three books on leadership: Leading from the Front, Spark, and Bet on You. She's a regular contributor to publications like Harvard Business Review, Fast Company, and Inc. For the past 20 years, Angie has worked with major organizations such as Google, FedEx, and Boston Scientific, helping them develop leadership potential through keynotes, consulting, and coaching. Passionate about empowering others, she shares insights via her blog, social media, podcast, and online courses. When she's not helping others succeed, Angie enjoys spending time with her two boys and training for her next race by the lakeside in Traverse City, Michigan.     Connect with Angie: LinkedIn: https://www.linkedin.com/in/theactualangie/ Website: https://angieconnect.com/   Connect with Allison: Feedspot has named Disruptive CEO Nation as one of the Top 25 CEO Podcasts on the web, and it is ranked the number 6 CEO podcast to listen to in 2025! https://podcasts.feedspot.com/ceo_podcasts/ LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/ Website: https://www.disruptiveceonation.com/    #CEO #leadership #startup #founder #business #businesspodcast  Learn more about your ad choices. Visit megaphone.fm/adchoices

Ee acordo com os dados do Ministério da Saúde de 2023, quase 25% da população têm obesidade. A condição também pode contribuir para o surgimento de uma série de problemas de saúde associados, estigma e preconceito que pessoas com sobrepeso encaram na sociedade e mais.Neste episódio, o dr. Drauzio Varella conversa com o dr. Almino Ramos, cirurgião bariátrico, e o dr. Eduardo Grecco, gastrocirurgião e endoscopista, sobre os tratamentos disponíveis e as novidades no enfrentamento à obesidade. Conteúdo produzido com o apoio da Boston Scientific e seu canal Saber da Saúde. Acesse: Leve a Vida Mais LeveVeja também: O Wegovy é uma opção segura para tratar a obesidade?

Jennifer Kaplan is the founder and CEO of Evolve Public Relations and Marketing, a premier PR agency she established in 2010 to help businesses and professionals authentically tell their stories. With a communications degree from Arizona State University and an entrepreneurial spirit, Jennifer has dedicated her career to elevating brands, building trust, and fostering meaningful connections.Jennifer comes from a family of entrepreneurs, so forging her own path was a no-brainer! As a young professional, she left her steady sales job to take on her first client, boldly launching herself into the rest of her career. In 2005, she co-founded her first PR start-up, PRIME 3, LLC, but later sold her share to branch out and start Evolve! Now, her team works across industries to provide media coverage, influencer engagement, reputation management, and crisis communications.Jennifer's work has garnered widespread acclaim. She's been honored as one of “The Most Influential Women in Arizona Business” by AZ Business Magazine, a “40 Under 40” by Phoenix Business Journal, a “Woman of Achievement” by InBusiness Magazine, and the inaugural Hugh Downs School of Human Communication Alumni of the Year.When Jennifer isn't running her agency, she fills her cup with yoga, cheering on the ASU Sun Devils, and of course, spending time with her family. Connect with Jennifer Kaplan and Evolve PR & Marketing:

What You'll Learn:Why real leaders don't always have the title—or the powerHow Becky's Stoic-inspired Choose the Handle That Holds became a guidebook for life and leadershipThe difference between authentic vulnerability and oversharingA live demo of STOA: a goal-setting tool you'll want to use immediatelyHow to model leadership for your team, your family, and yourself 

In this episode of Medsider Radio, we sat down with Maulik Nanavaty, CEO of Anumana. Anumana, an AI-driven health technology company focused on cardiovascular care, is taking a pragmatic approach to scaling AI in medicine.Maulik is a seasoned healthcare executive with over 30 years of global experience in the medical device industry. He spent 18 years at Boston Scientific, where he led its $1B+ Neuromodulation division and served as President of Boston Scientific Japan. Prior to that, he held leadership positions at Baxter. Known for driving innovation in implantable and artificial intelligence (AI)-powered technologies, Maulik also serves on the board of Rani Therapeutics.In this interview, Maulik shares why building a strong risk-benefit case and designing around real-world clinician needs are key to adoption. With data from over 20 million patients and a focus on transparency, Anumana is reshaping how AI reaches the point of care.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Maulik Nanavaty.

One of the possibilities along the Parkinson's journey is losing the ability to drive safely. This possibility is a scary one. For many, driving equals independence. So, it means more than just the hassle of getting around. It means losing your independence. It can lead to depression and anxiety. However, it is important to be safe on the road while driving a multi-ton vehicle. We must protect ourselves, our family, and others on the road. So, we are talking today with an Occupational Therapist who is so passionate about this topic that she started a business focused on helping people keep their independence if possible. She will take us through the when, why, how of driving while diagnosed with Parkinson's. OTs are the professionals trained to assess patients on activities of daily living which includes testing people on their driving skills. We discuss the testing process and the legal implications. There are many options for people once it is determined there is a driving defiicit. So, don't give up. Ask an Occupational Therapist for suggestions.  Listen in to learn everything about driving with PD. https://drivingtoindependence.com/ https://www.aded.net/? https://www.dbsandme.com/17branches Thank you to our sponsor – Boston Scientific, the maker of Vercise Genus, a Deep Brain Stimulation or DBS system. To learn more about the latest treatment options for Parkinson's disease at https://DBSandMe.com/17branches   

Live from Medtech MVP, Michael Mahoney, chairman and CEO of Boston Scientific Corp, sits down with Medtech Talk podcast host Justin Klein. They discuss Mahoney's communications strategies to align expectations and convey intentions to shareholders, how to delegate and streamline decision making, and advice on doing better as a partner. Mahoney also shares which second order considerations (such as manufacturing) are important to keep in mind, as well as whether he's a “war time” or “peace time” CEO and what challenges the industry needs to address today to create a better tomorrow.   Medtech Talk Links:  Cambridge Healthtech Institute   Medtech Talk  Gilde Healthcare  Boston Scientific Corp: Boston Scientific Corp 

Where do you exercise? Is there a place you can take classes specific for people with Parkinson's? Is it convenient? I know of only a handful of cities where there is a one stop fits all approach to PD wellness. Most are created and managed by someone stepping up and doing the work to make it happen for their community and beyond. I am excited to highlight some of these magical places where people with Parkinson's take classes designed for their needs, provide social support, and community. I am thrilled to bring. you this first magical place. It is in the greater the Austin, TX area and on their YouTube chamnnel. Power For Parkinson's was founded by two women, Dr. Nina Mosier and Susan Stahl. They both had fathers with Parkinson's and saw a need, so they found a way to provide research-based exercises while offering them for FREE. With nine locations, the classes are very accessible. Add in the YouTube channell with available streaming and on demand videos all for free, well that is magical. After listening to my guest today, you are going to want to have a similar opportunity in your area as well. Listen on. https://www.powerforparkinsons.org/ https://www.powerforparkinsons.org/youtubeq https://www.dbsandme.com/17branches Thank you to our sponsor – Boston Scientific, the maker of Vercise Genus, a Deep Brain Stimulation or DBS system. To learn more about the latest treatment options for Parkinson's disease at https://DBSandMe.com/17branches   

D'éirigh le fostaithe Boston Scientific i gCathair na Gaillimhe os cionn €100 míle euro a bhailiú don Institiúid Taighde Ailse Brollaigh sa gcathair ag an deireadh seachtaine nuair a thug os cionn 200 fostaí de chuid an chomhlachta faoin dúshlán Peak 2 Peak Challenge.

What You'll Learn:Why the “Rule of Three” is a leadership game changerThe origin and impact of Atlas' TEDx talk: Start with WhoWhat pirate leadership teaches us about trust and motivationWhy success leaves clues—and how to collect themThe mindset shift from chasing opportunities to choosing legacy Leadership Gold:“Every leader I've admired kept it simple: People. Time. Money.” The Rule of 3.  Resources & Links:Download Atlas' "Best-Selling Book" ProcessWatch his TEDx Talk: Start with WhoConnect with Atlas on his podcast: TargetedAnd, follow him on LinkedIn for more great insights.  

Today, I'm talking with Brittany Honor—a dynamic leader with more than 12 years of experience spanning the medical device and consumer packaged goods industries. In this inspiring and practical conversation, Brittany and I dig into the realities of learning and development, change management, and field enablement—particularly in fast-paced and high-performing sales-driven organizations. Through candid stories, tactical strategies, and reflections on her own journey, Brittany equips L&D and talent professionals to navigate change, support teams, and elevate their careers with authenticity and impact.Subscribe to our weekly updates and monthly talent development newsletter here. Order Own Your Career Own Your Life on AmazonApply to Join us in the Talent Development Think Tank Community!This episode is sponsored by LearnIt, which is offering a FREE trial of their TeamPass membership for you and up to 20 team members of your team. Check it out here.Also iSpring Suite, an eLearning authoring tool that offers thousands of assets, quizes, and role play simulations. They are offering our listeners a free trial here. Connect with Andy here: Website | LinkedInConnect with Brittany Honor here: LinkedInIn this episode, Brittany shares:How she “fell into” L&D, moving from sales and leadership roles into developing future leaders.Why promoting top sales performers into management isn't always the answer—and the value of focusing on transferable leadership skills.The critical mindset shift from “super salesperson” to effective leader.Communication pitfalls in change management and why messaging must start with the most impacted groups.The importance of listening and needs assessments for successful technology and training rollouts.How to handle requests for training—often uncovering root causes like trust, not just surface skills.Why authenticity, vulnerability, and ownership are essential for leaders.The role of clarifying personal values in driving career satisfaction and growth.Practical ways to build your personal brand alongside a corporate L&D career.How networking (especially on social media) can open doors and boost your professional impact.Thanks for listening! Be sure to subscribe and share with your colleagues and friends.

Este año la ONU cumple 80 años, y sin ella el mundo no sería igual. En épocas de guerra es urgente defender la palabra, es lo único que nos salva. En la guerra nadie habla: las acciones violentas predominan. A través de este podcast te invitamos a que te unas a la defensa del diálogo pacífico. Hacemos un breve recuento sobre los primeros pasos del derecho internacional y los derechos humanos, desde regulaciones tempranas como las de Aragón y Castilla en la defensa de los indios en el Imperio Español, pasando por principios universales de Emmanuel Kant, y llegando al crisol del pensamiento liberal en América, después de las independencias del siglo XIX. A partir de allí abordamos cómo se gestó la ONU, sus características, visiones y sus más importantes aportes durante el siglo XX. La ONU ayudó a descolonizar el mundo de pensamientos imperiales y todavía hoy lucha, a pesar de todo, por la seguridad, la libertad y la dignidad humana. Notas del episodio:   Este episodio fue traído a ustedes gracias a Boston Scientific  Si estás interesado en pensar los terribles acontecimientos del hoy, pero no quieres perder la esperanza en el intento, visita la columna de Rodrigo Uprimny: “”Un deber activo de esperanza?”, nuestro invitado especial para la realización de este podcast. Si quieres conocer más acerca del papel mundial de la ONU, desde su nacimiento hasta nuestros días, consulta los eventos oficiales destacados en la Historia de la ONU. Si quieres indagar más sobre el papel de Colombia en la ONU, te recomendamos dos textos: 1) “Colombia en la Asamblea General de las Naciones Unidas, 1946-2021 Construcción – Protagonistas – Discursos”, publicado por la Cancillería de Colombia, y 2) “Colombia en la ONU: 1945 - 1995” de Álvaro Tirado Mejía. Para comprender las complejidades que enfrenta la ONU desde sus dos grandes tensiones, “Idealismo vs. Realismo geopolítico” y “Universalismo vs. Reconocimiento de soberanías”, te invitamos a consultar el libro “Por una Constitución de la Tierra - La humanidad en la encrucijada” de Luigi Ferrajoli. Para conocer más sobre cómo funciona la crueldad de la guerra, te recomendamos revisar el libro “Calle Este-Oeste - Sobre los orígenes de “genocidio” y “crímenes contra la humanidad” de Phillipe Sands. No renunciemos a la esperanza.   Sigue mis proyectos en otros lugares:  YouTube ➔ youtube.com/@DianaUribefm  Instagram ➔ instagram.com/dianauribe.fm Facebook ➔ facebook.com/dianauribe.fm Sitio web ➔ dianauribe.fm Twitter ➔ x.com/DianaUribefm  LinkedIn ➔ www.linkedin.com/in/diana-uribe    Gracias de nuevo a nuestra comunidad de Patreon por apoyar la producción de este episodio. Si quieres unirte, visita www.dianauribe.fm/comunidad  

In this episode of Medsider Radio, we had a really engaging conversation with James (Jim) Corbett, CEO of AVITA Medical.AVITA Medical's RECELL system uses Spray-On Skin Cell technology to accelerate healing for patients with severe burns and wounds.  Jim brings nearly 40 years of medical device leadership experience to AVITA Medical. His career spans global commercial and operational roles, including President of Boston Scientific and General Manager of Scimed Life Systems. Jim has served as CEO of six companies, including three publicly traded entities — Microtherapeutics, ev3, and Alphatec Spine — as well as CathWorks, Home Diagnostics, and Vertos Medical.In this interview, Jim shares lessons from a career spanning global medtech leadership positions — including the importance of hands-on fundraising, adapting sales strategies as products mature, and how generating clinical evidence beyond FDA requirements serves commercial adoption.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Jim Corbett.

In this episode of Medsider Radio, we sat down with Todd Usen, CEO of Adagio Medical.Adagio specializes in catheter-based ablation technologies for the treatment of cardiac arrhythmias, with a focus on ventricular tachycardia (VT).  Todd has over three decades of leadership experience in the medical technology industry, with particular expertise in commercial strategy, operational performance, and business transformation. Before joining Adagio, Todd served as CEO of Minerva Surgical, a women's health company, and as CEO of Activ Surgical, a digital surgery startup. Todd has also served in executive positions at Olympus, United States Orthopedics, Smith and Nephew, and Boston Scientific.In this interview, Todd shares insights on making usability central to commercialization strategy, leveraging breakthrough designation beyond regulatory validation, and assembling effective boards by carefully selecting both investor and independent members who bring operational expertise.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Todd Usen.

Join HRS Board Member Prashanthan Sanders, MBBS, PhD, FHRS (University of Adelaide) as he discusses this exciting paper, presented at Heart Rhythm 2025. He is joined in the Heart Rhythm Tv Studio in San Diego, California by Louise Segan, MBBS, MPH (Alfred Health), and Takanori Yamaguchi, MD, PhD (Saga University). This discussion took place on-site at Heart Rhythm 2025.   https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(25)01245-7/fulltext Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical, Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical Contributor Disclosure(s): T. Yamaguchi: Honoraria/Speaking/Consulting: Abbott Japan, Biotronik, Boston Scientific, Abbott Medical, Japan Medtronic, Inc., Daiichi Sankyo, Novartis, Japan Lifeline, Nihon Kohden, Bayer Healthcare Pharmaceuticals Japan, Boehringer Ingelheim L. Segan: Nothing to disclose.

In this episode of the Latin Wealth Podcast, we dive into major developments shaping Latin America's economic and political landscape in 2025. From Costa Rica's quiet rise as a high-tech powerhouse to China's growing influence across Latin America — and the unexpected shift of Latin American migration from the U.S. to Spain — we break down what these global shifts mean for Latinos around the world.Segment 1: Costa Rica's Tech TransformationCosta Rica is becoming Latin America's high-tech hub, recording over $32 billion in exports in 2024. With investments from global tech giants like Intel and Boston Scientific, and a booming medical device sector, this Central American nation is showing the power of innovation, sustainability, and national branding. We discuss how this model could inspire other countries in the region.Segment 2: China's Visa-Free PlayChina is expanding visa-free travel to citizens of Brazil, Argentina, Chile, Peru, and Uruguay. This is more than a tourism policy — it's a strategic move to deepen China's presence in Latin America. We discuss what this means for global partnerships, trade routes, and diplomatic influence in the Western Hemisphere.Segment 3: “The American Dream is Over?”Trump's aggressive deportation policies are causing many Latin Americans to abandon the U.S. for Spain. We explore how political pressure, cultural ties, and economic opportunity are reshaping migration patterns, and what this means for Latinos chasing opportunity abroad.This episode covers:- Latin America's tech innovation and economic growth- China's bold diplomatic strategies in the region- How shifting immigration policies are changing the Latino diaspora- The future of the American Dream for Latin communities

Prashanthan Sanders, MBBS, PhD, FHRS, University of Adelaide is joined by Jenish Shroff, MBBS, MD, Australian National University, and Pugazhendhi Vijayaraman, MD, FHRS, Geisinger Heart Institute, to discuss this first-in-human feasibility study evaluated a novel helix-based leadless pacemaker (LPCSP) designed to achieve left bundle branch area pacing (LBBAP), a capability current LPs lack. The device was temporarily implanted via the internal jugular vein into the interventricular septum in 14 patients, with successful implantation in 10. Electrical performance metrics, including pacing threshold, R-wave amplitude, and impedance, were within acceptable clinical ranges. LBBAP capture was achieved in 5 patients, with no serious device-related adverse events in 85.7% of cases. The study supports the acute safety and feasibility of LPCSP for conduction system pacing.    https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(25)02378-1/fulltext Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical, Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical Contributor Disclosure(s): P. Vijayaraman: Honoraria/Speaking/Consulting: Biotronik, Boston Scientific, Abbott Medical, Medtronic, Inc. Research (Contracted Grants for PIs and Named Investigators only): Medtronic Fellowship Support: Medtronic J. Shroff: Nothing to disclose.

Host: Susanna Price Guest: J. Wouter Jukema Want to watch that extended interview on LDL management? Go to: https://esc365.escardio.org/event/1807?resource=interview Want to watch the full episode? Go to: https://esc365.escardio.org/event/1807 Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. J. Wouter Jukema has declared to have potential conflicts of interest to report: J. Wouter Jukema/his department has received research grants from and/or was speaker (CME accredited) meetings sponsored/supported by Abbott, Amarin, Amgen, Athera, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Edwards Lifesciences, GE Healthcare Johnson and Johnson, Lilly, Medtronic, Merck-Schering-Plough, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis,Shockwave Medical, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Netherlands Heart Institute and the European Community Framework KP7 Programme. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers:  Cardiology this Week: A concise summary of recent studies Coronary sinus reducer: promise in refractory angina Best strategies to reach LDL cholesterol goals in high-risk patients Snapshots Host: Susanna Price Guests: Carlos Aguiar, Rasha Al-Lamee, J. Wouter Jukema, Steffen Petersen Want to watch that episode? Go to: https://esc365.escardio.org/event/1807 Want to watch that extended interview on LDL management? Go to: https://esc365.escardio.org/event/1807?resource=interview Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Rasha Al-Lamee has declared to have potential conflicts of interest to report: speaker's fees for Menarini pharmaceuticals, Abbott, Philips, Medtronic, Servier, Shockwave, Elixir. Advisory board: Janssen Pharmaceuticals, Abbott, Philips, Shockwave, CathWorks, Elixir. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. J. Wouter Jukema has declared to have potential conflicts of interest to report: J. Wouter Jukema/his department has received research grants from and/or was speaker (CME accredited) meetings sponsored/supported by Abbott, Amarin, Amgen, Athera, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Edwards Lifesciences, GE Healthcare Johnson and Johnson, Lilly, Medtronic, Merck-Schering-Plough, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, Shockwave Medical, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Netherlands Heart Institute and the European Community Framework KP7 Programme. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Johns Creek: Number One Best U.S. City to Live In, with Mayor John Bradberry and Brian Lynam, Boston Scientific (GNFCC 400 Insider, Episode 107) Join GNFCC CEO Kali Boatright in this episode of the GNFCC 400 Insider podcast as she chats with Johns Creek Mayor John Bradberry and Boston Scientific Senior Director Brian Lynam, discussing […] The post Johns Creek: Number One Best U.S. City to Live In, with Mayor John Bradberry and Brian Lynam, Boston Scientific appeared first on Business RadioX ®.

Michael S. Lloyd, MD, FHRS, Emory University is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Christopher C Cheung, MD, MPH, FHRS, Sunnybrook HSC, University of Toronto, to discuss the VOLT-AF IDE study evaluated the safety and effectiveness of a novel balloon-based pulsed field ablation (PFA) catheter system for treating paroxysmal and persistent atrial fibrillation (PAF and PsAF). Conducted at 34 global sites, the study enrolled 394 subjects, with 320 included in the primary analysis. Acute pulmonary vein isolation (PVI) success was achieved in over 99% of veins, and primary serious adverse events occurred in only 1.9% of patients, with no significant complications like esophageal injury or hemolysis. Procedure metrics showed efficient operation times, and early 6-month data suggest promising effectiveness. These initial findings support the Volt™ PFA system as a safe and effective treatment option for AF.    https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(25)02168-X/fulltext Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Arga Medtech, Circa Scientific Membership on Advisory Committees: Boston Scientific Contributor Disclosure(s):   E. Gerstenfeld: Honoraria/Speaking/Consulting: Medtronic, Boston Scientific, Biosense Webster, Abbott, Varian Medical Systems, Biotronik Other Non-Financial Relationships: Farapulse, Adagio Medical, Boston Scientific, Abbott Medical, Research (Contracted Grants for PIs and Named Investigators only): Abbott Medical Officer, Trustee, Director, Committee Chair, or Any Other Fiduciary Role: American College of Cardiology Foundation C. Cheung: Nothing to disclose.

Sandeep A Saha, MD, MS, FHRS, Oregon Heart Center PC is joined by Saket Sanghai, MD, FHRS, Oregon Health & Science University, and Naga Venkata Krishna Chand Pothineni, MD, Kansas City Heart Rhythm Institute, to discuss how the study evaluated the effectiveness of implantable loop recorders (ILRs) in detecting arrhythmias in patients with hypertrophic cardiomyopathy (HCM). Traditional monitoring methods, like Holter monitors, often miss intermittent arrhythmic events in HCM patients. ILRs, offering continuous long-term monitoring, were found to identify clinically significant arrhythmias that might otherwise go undetected. The findings suggest that ILRs can play a crucial role in risk stratification and management of HCM patients, potentially guiding decisions regarding interventions such as implantable cardioverter-defibrillator (ICD) implantation. Overall, ILRs enhance the detection of arrhythmias in HCM, leading to improved patient care.    https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacep.2025.03.005 Host Disclosure(s): S. Saha: Honoraria/Speaking/Consulting Fee: Medtronic Membership on Advisory Committees: Medtronic Inc. Contributor Disclosure(s): S. Sanghai: Research: Siemens Healthcare Stocks (Publicly Traded): Apple Inc., Alphabet Inc., Amazon Stock Options (Publicly Traded): Intel K. Pothineni: Honoraria/Speaking/Consulting Fee: Medtronic, Inc., Biosense Webster, Inc., Boston Scientific

In this episode of the Next Level Healing Podcast, Dr. Tara Perry interviews John K. Bates, Founder of Executive Speaking Success. John has trained and coached leaders at NASA—including the astronauts—GE Aerospace, US Navy Special Operations, Johnson & Johnson's JLABS, Boston Scientific, Google, Intuit, and many more. His programs consistently earn Net Promoter Scores of 92+, and his clients don't just thank him—they recommend him as the best leadership communication coach working today.Work with Dr. Tara PerryTune in every week for a new episode of Next Level Healing. Subscribe on your favorite podcasting platform and never miss an episode!

Mais de 10 milhões de pessoas no mundo são afetadas pelo mal de Parkinson, e esse número pode dobrar até 2050. Não há, ainda, cura, mas as terapias de estimulação cerebral profunda, conhecidas como DBS, combinam dispositivos digitais com implantes cerebrais para mudar a vida de quem sofre com doenças neurodegenerativas. Como funcionam esses marca-passos cerebrais e como a IA os torna ainda mais precisos? Conversamos com o diretor de neuromodulação da Boston Scientific no Brasil, Lucas Silva, para entender essa história, cheia de finais felizes.Links do episódioA página do LinkedIn de Lucas SilvaO site Viver com ParkinsonO documentário "Still - ainda sou Michael J. Fox", na Apple TV+A série "Shrink - Falando a Real", na Apple TV+O livro "The Ageless Brain: How to Sharpen and Protect Your Mind for a Lifetime", de Dale BredesenO livro "Uma viagem pelo cérebro. A via rápida para entender neurociência", de Carla Tieppo A The Shift é uma plataforma de conteúdo que descomplica os contextos da inovação disruptiva e da economia digital.Visite o site www.theshift.info e assine a newsletter

They're good dogs, especially when Kasey Labelle joins us to share her lifelong connection with puppies. She recounts her childhood with two family dogs before introducing Rhino, her beloved blue nose pitbull who chose her when he was just three weeks old and remained her companion for nearly 15 years. Kasey discusses how she's coped with Rhino's passing by becoming a dog walker, speaks passionately about the misconceptions surrounding pitbulls, and shares how Rhino's loving personality challenged those stereotypes. She also offers thoughtful advice for potential dog owners, emphasizing the importance of viewing dogs as family members and the different factors to consider when choosing the right dog.Guest BioKasey Labelle, CPWA (she/her) is a UX and design engineering leader with a passion for design systems and accessibility. In her current role as a Design Architect at iSeatz, she's leading the evolution of a design system that powers a white-label travel loyalty platform. Previously, she built and led the multi-disciplinary design system team and accessibility program at Boston Scientific, establishing 0-1 and 1-n strategies and serving as a player-coach. In her downtime, you can find her at the beach, an art museum, concert, or game night; walking dogs; obsessing over spreadsheets; traveling; or attending fine arts and crafts workshops with friends.LinksKasey's website: kaseyllabelle.comKasey on LinkedIn: linkedin.com/in/kaseyllabelleCreditsCover design by Raquel Breternitz.

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

This episode covers: Cardiology This Week: A concise summary of recent studies Colchicine for secondary prevention An algorithmic approach to the workup of syncope Milestones: CIBIS II Host: Rick Grobbee Guests: Carlos Aguiar, Sanjit Jolly, Michele Brignole Want to watch that episode? Go to: https://esc365.escardio.org/event/1805 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Michele Brignole, Diederick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Sanjit Jolly has declared to have potential conflicts of interest to report: grant support from Boston Scientific, honorarium from Boston Scientific, Shockwave, Abiomed, SIS, and Teleflex.  Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Join host Prashanthan Sanders, MBBS, PhD, FHRS, and episode guests Jason G. Andrade, MD, FHRS, and Melanie Gunawardene, MD, as they discuss Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation. This discussion was recorded in person at EHRA 2025 in Vienna, Austria. The article under discussion was presented at EHRA 2025 and simultaneously published in the New England Journal of Medicine.   https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2502280   Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical; Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical   Contributor Disclosure(s): M. Gunawrdene: Honoraria/Speaking/Consulting: Farapulse, Abbott Medical, Boston Scientific, Medtronic, Biotronik, Luma Vision, Bristol Myers Squibb J. Andrade: Honoraria/Speaking/Consulting: Boston Scientific, Medtronic, Inc., Biosense Webster, Inc.

In this episode, a multidisciplinary panel of PE key opinion leaders share insights and challenge perceived myths within the landscape of PE real world evidence and care. Listen in for the latest data, contemporary treatment strategies, and preview anticipated future developments in this rapidly evolving field of PE.

In this episode, the Surgical Endoscopy team, accompanied by Chief Medical Officer Dr. Brian Dunkin of Boston Scientific, review primary and revisional endoscopic treatment options for bariatric patients. They focus on the emerging data available for procedures such as endoscopic sleeve gastroplasty (ESG) and endoscopic gastrojejunal revision (EGJR) and offer technical tips on how to perform the procedures. In addition, they discuss accessibility challenges for patients and provide insight into the future direction of bariatric endoscopy as a field.  Hosts: ·      Dr. Sullivan “Sully” Ayuso, Minimally Invasive Surgery, Endeavor Health (Evanston, IL), @SAyusoMD (Twitter) ·      Dr. Trevor Crafts, Minimally Invasive Surgeon, Rocky Mountain VA Medical Center (Denver, CO), @CraftsTrevor (Twitter)  ·      Dr. H. Masson Hedberg, Minimally Invasive Surgeon, Endeavor Health (Evanston, IL) ·      Dr. Michael Ujiki, Professor and Louis Biegler Chair of Surgery, Endeavor Health (Evanston, IL), @UjikiMike ·      Dr. Brian Dunkin, Chief Medical Officer at Boston Scientific, @briandunkinmd Learning Objectives:  -       Identify and Describe Common Endobariatric Procedures: Learners will be able to name and briefly describe at least three common endobariatric procedures discussed in the episode, including Endoscopic Sleeve Gastroplasty (ESG), Endoscopic GJ Revisions (Transoral Outlet Reduction - TORR/EGJR), and Intragastric Balloons, along with their historical context and evolution. -       Explain the Mechanism and Benefits of Endoscopic Sleeve Gastroplasty (ESG): Learners will be able to articulate the procedural technique of ESG, including the U-shaped suture pattern, its impact on gastric volume reduction, and the proposed mechanisms of weight loss, such as slowed gastric emptying and hormonal changes, as compared to laparoscopic sleeve gastrectomy. -       Discuss the Role of Technology and Training in Endobariatrics: Learners will be able to explain the significance of endoscopic suturing devices like the Overstitch in the advancement of endobariatric procedures and recognize the importance of specialized training, including the recommendations against fundal suturing for safety during the initial learning curve. -       Compare and Contrast Endobariatric Procedures with Surgical and Pharmacological Obesity Treatments: Learners will be able to discuss the position of endobariatric procedures as a "gap therapy" in the spectrum of obesity treatments, highlighting their benefits such as reduced invasiveness, lower complication rates, faster recovery, and increased patient access compared to surgery, as well as their potential role in conjunction with pharmacologic therapies like GLP-1 agonists. -       Recognize Key Considerations and Potential Complications of Endobariatric Procedures: Learners will be able to identify important technical considerations during ESG, such as achieving full-thickness bites while avoiding injury to adjacent organs, and describe common post-procedure issues associated with intragastric balloons, including nausea, vomiting, and the need for general anesthesia during removal. Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity: https://pubmed.ncbi.nlm.nih.gov/39888616/ Surgical Endoscopy Series Ep. 1: An Introduction to Surgical Endoscopy: https://app.behindtheknife.org/podcast/surgical-endoscopy-series-ep-1-an-introduction-to-surgical-endoscopy Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode of Medsider Radio, we sat down with Randy Pritchard and Erica Rogers, leaders of Axena Health. Axena is transforming pelvic floor therapy with Leva, a device bringing clinically-proven, supervised pelvic floor muscle training into women's homes. Randy, CEO of Axena, brings nearly 25 years of healthcare experience to the company, most recently as CEO of Pillar Biosciences and previously holding leadership positions at Roche Diagnostics, where he spent 18 years developing commercial expertise. Erica, who sits on Axena's Board of Directors, spent a decade as President and CEO of Silk Road Medical, leading the company from early clinical trials through IPO and eventual acquisition by Boston Scientific. A returning guest to the podcast after nearly half a decade, Erica previously held roles at Medicine360, co-founded two other medical device companies, and spent over 12 years at Boston Scientific prior to her role at Silk Road.In this interview, they share essential medtech commercialization insights: identify your specific patient segment, build continuous clinical evidence, and communicate consistently with investors. Their experience offers invaluable lessons for medical device entrepreneurs navigating today's complex healthcare landscape.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Randy Pritchard and Erica Rogers.

Jacob Raymer is an internationally recognized speaker who addresses corporate, public and universityaudiences on the subjects of leadership roles and responsibilities, cultural transformation, and how to achieveorganizational excellence with the right behavior and sustainable long-term results. As the Shingo Institute'sformer Director of Education, Jacob co-created the Shingo Model and developed the foundational learningcourses taught at the Shingo Institute. He has trained Shingo examiners and thousands of individualsworldwide on how to assess and establish lean mindsets and method. In 2006, Jacob pioneered the concept ‘key behavior indicators' (KBIs). Today many world-wide organizations have now adopted this term and concept to expand their desired outcomes with key performance indicators(KPIs). By combining KPI and KBI, Jacob's consulting firm has led the development and application of behavior-based strategy deployment; building systems to drive the right behavior; and developing internal behavioralassessments. The United State Airforce invited Jacob to join a team of global subject matter experts to create their leanleadership development program (AFSO21) in 2006. He was commissioned to lead the leadershipdevelopment for United States Airforce Europe – working with leaders throughout 93 countries. His workchallenged leaders' mindsets around lean tools and how to lead by integrating guiding principles.After spending over a decade with the Shingo Institute he joined Munson Healthcare, northern Michigan'slargest healthcare system as their Chief Transformation Officer. At Munson Healthcare, Jacob spent sevenyears creating and deploying an organizational lean operating system and alignment framework anchored toguiding principles that are now integrated into nine hospitals and over 150 clinics. Currently Jacob supports the Shingo Institute as a Faculty Fellow by continuing his work in creating learning frameworks to help organizations effectively integrate the Shingo Model. He was recognized and awarded as alifetime member to the Shingo Academy in 2021 for his global contributions to operational excellence. Jacob continues to support various organizations through executive coaching and consulting. Current companies include: Amazon, General Motors, Android, UCLA Healthcare System, University of KansasHealthcare System and University of New Mexico Healthcare System Past organizations include: 3M, Raytheon Missile Systems, Boston Scientific, Boeing, Daimler, Intermountain Healthcare, Perrigo, Canadian Government-EDC, Switzerland Government-HealthcareLink to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Want to thrive in medical sales? In this episode, TJ, a regional business director specializing in cardiology, shares insider strategies for success—from fostering a growth mindset to mastering self-leadership. Learn how top performers refine their processes, understand their motivations, and leverage innovation to drive sales in coronary artery disease and structural heart technologies.   Discover why psychology beats tactical selling when building strong healthcare partnerships and how relationship-building is the key to long-term success. TJ also reveals how Boston Scientific onboards new reps to ensure they make an impact from day one, engaging effectively with hospital accounts.   Thinking about breaking into medical sales from a different industry? We explore how a restaurant server can successfully pivot into medical sales, the importance of demonstrating growth, and what hiring managers look for in standout candidates. Plus, get expert tips on acing interviews, crafting personalized follow-ups, and making authentic connections that lead to opportunities.   Whether you're a seasoned rep, an aspiring medical sales professional, or a leader looking to build a high-performing team, this episode is packed with real-world insights, career strategies, and actionable advice to help you succeed in the dynamic world of medical sales.   Meet the guest: TJ Jones is a Regional Sales Director for Boston Scientific, a global company that transforms lives through innovative medical solutions. He is passionate about positively impacting patient care and helping sales professionals reach new milestones professionally and personally. Connect with TJ: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!